You will receive alerts when there are new announcements on Arsanis Inc
Only registered members can use this feature.
Arsanis Inc (NASDAQ:ASNS) is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.